| Issue | Title | |
| Vol 2, Issue 2 (2022) | "Multiomic" Studies as a Promising Clinical Pharmacological Tool for Personalization of Socially Significant Diseases Pharmacotherapy in Russia | Abstract PDF (Eng) |
| D. A. Sychev | ||
| Vol 4, Issue 4 (2024) | Neuroinflammation as an Integral Component of Neurodegeneration in Parkinson's Disease | Abstract PDF (Eng) |
| Z. F. Sayfitdinkhuzhaev, N. G. Zhukova, A. N. Baidanova | ||
| Vol 4, Issue 3 (2024) | Neuroprotective Activity of GLP-1 Analogues: General Understanding of Implementation Mechanisms | Abstract PDF (Eng) |
| E. L. Golovina, O. E. Vaizova, J. G. Samojlova | ||
| Vol 4, Issue 3 (2024) | Neutrophil-to-Lymphocyte Ratio Any Association with Metabolic Syndrome in Schizophrenia | Abstract PDF (Eng) |
| N. V. Zakharova, R. F. Nasyrova, A. I. Rakhmatullin, M. N. Rumiantceva, K. I. Sizykh, F. N. Kostin | ||
| Vol 3, Issue 1 (2023) | New Hope: Using Gene Therapy to Treat Rare Neurological Diseases | Abstract PDF (Eng) |
| A. A Rizvanov | ||
| Vol 2, Issue 2 (2022) | Pathophysiological and Genetic Aspects of the Brain–Skin Axis: The Role of Stress and Inflammation in Skin Aging | Abstract PDF (Eng) |
| O. B. Borzykh | ||
| Vol 2, Issue 1 (2022) | PCR-based Approach for Determining the Genetic Risk Factors of Antipsychotic-Induced Metabolic Disorders | Abstract PDF (Eng) |
| K. O. Mironov, I. I. Gaponova, V. I. Korchagin, A. S. Esman, E. A. Dunaeva, V. A. Zhivotova, V. S. Dobrodeeva, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 1, Issue 2 (2021) | Personalized approach to addiction care | Abstract PDF (Eng) |
| E. M. Krupitsky | ||
| Vol 1, Issue 1 (2021) | Personalized approach to antipsychotic-induced weight gain prognosis | Abstract PDF (Eng) |
| V. S. Dobrodeeva, A. K. Abdyrahmanova, R. F. Nasyrova | ||
| Vol 5, Issue 1 (2025) | Personalized approach to prediction and prevention of haloperidol-induced metabolic syndrome | Abstract PDF (Eng) |
| V. V. Grechkina, N. A. Shnayder | ||
| 51 - 60 of 99 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Alzheimer's disease
Parkinson's disease
adverse reaction
antiepileptic drugs
antipsychotic
antipsychotics
anxiety
biomarkers
candidate genes
epilepsy
genes
genetics
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
treatment
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
